Physician profile
James J Logan
NPI 1881630655
$1,140.57
in general payments reported to CMS, 2019-2025
15 companies · $75.31 in 2025
The $75.31 reported for 2025 was less than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $272 · 2021: $243 · 2022: $253 · 2023: $29.22 · 2025: $75.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $104.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $224.66 | 2019-2022 | |
| Glaxosmithkline, LLC. | $191.32 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $161.40 | 2019-2022 | |
| Pfizer INC. | $146.38 | 2019-2025 | |
| Genzyme Corporation | $137.30 | 2019-2022 | |
| Advanced Respiratory, INC | $123.70 | 2020-2021 | |
| Baxter Healthcare | $37.83 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Grifols USA, LLC | $21.74 | 2022 | |
| Fisher & Paykel Healthcare INC | $16.00 | 2023 | Fisher & Paykel Healthcare |
| Global Blood Therapeutics, INC. | $15.02 | 2022 | |
| Biogen, INC. | $14.12 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.84 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $13.04 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.48 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Logan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.